Comparison

Ruxolitinib (S enantiomer) European Partner

€142.00
Excl. VAT
Item no. HY-50856A-50mg
Manufacturer MedChem Express
CASRN 941685-37-6
Amount 50 mg
Category
Type Inhibitors
Specific against other
Purity 99.92
Formula C17H18N6
Citations [1]Hye Kyung Lee, et al. JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells. Commun Biol. 2021 Jun 2;4(1):654.
[2]Lorena Arranz, et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms. Nature. 2014 Aug 7;512(7512):78-81.
Smiles N#CC[C@@H](C1CCCC1)N2N=CC(C3=NC=NC4=C3C=CN4)=C2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias S-Ruxolitinib; S-INCB18424
Similar products 941685-37-6
Available
Product Description
Ruxolitinib (S enantiomer) (S-Ruxolitinib) is the S-enantiomer of Ruxolitinib (HY-50856). Ruxolitinib (S enantiomer) is an orally active, potent JAK inhibitor[1][2].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
Molecular Weight
306.37
Clinical Information
Launched
Solubility
1M HCl : 50 mg/mL (ultrasonic; adjust pH to 1 with HCl)|DMSO : ≥ 100 mg/mL
Isoform
JAK
Pathway
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
Listprice: €142.00
Price: €142.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close